Therapy for inflammatory breast cancer: Impact of doxorubicin-based therapy-Reference-Cited by-同舟云学术

Therapy for inflammatory breast cancer: Impact of doxorubicin-based therapy

Published:1995-07 Issue:4 Volume:2 Page:288-294
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Annals of Surgical Oncology

Author:

Bauer Ronald L.,Busch Erna,Levine Ellis,Edge Stephen B.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/BF02307059.pdf

Reference31 articles.

1. Levine PH, Steinhorn SC, Ries LG, Aaron JL. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) Program.J Natl Cancer Inst 1985;74:291–7.

2. Bell C.A System of Operative Surgery, vol 2. Hartford, Connecticut: Hale and Hosmer, 1814:136.

3. Klotz H.Ueber mastitis carcinomatosa gravidarum et Lactantium. Halle, Germany: Lipke, 1869:30.

4. Leitch A. Peau d'orange in acute mammyary carcinoma. Its causes and diagnostic value.Lancet 1909;1:861–3.

5. Learmonth G. Acute mammary carcinoma (Volkman's mastitis carcinomatosis).Can Med Assoc J 1916;6:499–511.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapy for Inflammatory Breast Cancer;Breast Disease;2019

2. Inflammatory Breast Cancer;Breast Cancer;2018-10-30

3. The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?;Expert Review of Anticancer Therapy;2017-05-25

4. Inflammatory and Locally Advanced Breast Cancer;Management of Breast Diseases;2016

5. Systemic Therapy for Inflammatory Breast Cancer;Breast Disease;2016